Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05371145
PHASE1/PHASE2

Carnosine for Peripheral Arterial Disease Patients

Sponsor: Shahid Baba

View on ClinicalTrials.gov

Summary

Oral supplementation of L-carnosine will increase muscle carnosine, stabilize HIF1-alpha promote angiogenesis, and thus improve the functioning of lower extremities in PAD patients.

Official title: Carnosine for Peripheral Arterial Disease Patients (Car-PAD)

Key Details

Gender

MALE

Age Range

50 Years - 80 Years

Study Type

INTERVENTIONAL

Enrollment

20

Start Date

2023-03-01

Completion Date

2024-12-30

Last Updated

2024-07-22

Healthy Volunteers

No

Interventions

BIOLOGICAL

Carnosine

Determine whether carnosine supplementation (2 g/day) for 3 months in peripheral arterial disease patients improves 6MWT ability.

Locations (1)

University of Louisville

Louisville, Kentucky, United States